Ischemic stroke as a complex genetic disorder

Seminars in Neurology

Volumn 26, Issue 1, 2006, Pages 49-56

  Meschia, James F ^a  

^a MAYO CLINIC   (United States)

Author keywords

Classification; Family history; Genetic research; Genomic research; Intermediate phenotypes; Ischemic stroke; Phenotypic variability

Indexed keywords

ARTERY MEDIA; CADASIL; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FAMILY HISTORY; GENE IDENTIFICATION; GENETIC DISORDER; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HAPLOTYPE; HEREDITY; HUMAN; INTIMA; LEUKOARAIOSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; REVIEW; RISK FACTOR; VALIDATION PROCESS;

EID: 33244464534     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933308     Document Type: Review

References (50)

1. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004;35:212-227
2. Hassan A, Lansbury A, Catto AJ, et al. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry 2002;72:343-346
3. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, et al. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 2003;34:1634-1639
4. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998;29:1177-1181
5. Turner ST, Jack CR, Fornage M, et al. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004;43: 483-487
6. Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004;35:1609-1613
7. Fox CS, Polak JF, Chazaro I, et al. Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study. Stroke 2003;34:397-401
8. Juo SH, Lin HF, Rundek T, et al. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke 2004;35:2243-2247
9. Lange LA, Bowden DW, Langefeld CD, et al. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 2002;33:1876-1881
10. Hunt KJ, Duggirala R, Goring HH, et al. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke 2002;33:2775-2780
11. Moskau S, Golla A, Grothe C, et al. Heritability of carotid artery atherosclerotic lesions: an ultrasound study in 154 families. Stroke 2005;36:5-8
12. Zureik M, Ducimetiere P, Touboul PJ, et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000;20: 1622-1629
13. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST-Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41
14. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998;79:1265-1272
15. Adams HP Jr, Woolson RF, Clarke WR, et al. Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Control Clin Trials 1997;18:358-377
16. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339:1415-1425
17. Hart RG. Prevention of stroke in atrial fibrillation: an update. Health Rep 1994;6:126-131
18. Kunitz SC, Gross CR, Heyman A, et al. The pilot Stroke Data Bank: definition, design, and data. Stroke 1984;15:740-746
19. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083-1092
20. Caplan LR, Hier DB, D'Cruz I. Cerebral embolism in the Michael Reese Stroke Registry. Stroke 1983;14:530-536
21. Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754-762
22. Spitzer K, Becker V, Thie A, et al. The Hamburg Stroke Data Bank: goals, design and preliminary results. J Neurol 1989; 236:139-144
23. Gordon DL, Bendixen BH, Adams HP Jr, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology 1993;43:1021-1027
24. Madden KP, Karanjia PN, Adams HP Jr, et al. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment. Neurology 1995; 45:1975-1979
25. Lee LJ, Kidwell CS, Alger J, et al. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000; 31:1081-1089
26. Goldstein LB, Jones MR, Matchar DB, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2001;32:1091-1097
27. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126-131
28. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994;25:2220-2226
29. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170
30. Schulz UG, Flossmann E, Rothwell PM. Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 2004;35:819-824
31. Meschia JF, Brott TG, Brown RD Jr, et al. The Ischemic Stroke Genetics Study (ISGS) protocol. BMC Neurol 2003; 3:4
32. Johnson CJ, Kittner SJ, McCarter RJ, et al. Interrater reliability of an etiologic classification of ischemic stroke. Stroke 1995;26:46-51
33. Kittner SJ, Stern BJ, Wozniak M, et al. Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998;50:890-894
34. Meschia JF. Addressing the heterogeneity of the ischemic stroke phenotype in human genetics research. Stroke 2002;33: 2770-2774
35. Martiskainen M, Pohjasvaara T, Mikkelsson J, et al. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke. Stroke 2003;34:886-891
36. Myllykangas L, Polvikoski T, Sulkava R, et al. Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study. Ann Med 2001;33:486-492
37. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, et al. Localization of a susceptibility gene for common forms of stroke to 5ql2. Am J Hum Genet 2002;70:593-603
38. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003;35:131-138
39. Funalot B, Varenne O, Mas JL. A call for accurate phenotype definition in the study of complex disorders. Nat Genet 2004;36:3 author reply 3-4
40. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011
41. Uchino K, Billheimer D, Cramer SC. Entry criteria and baseline characteristics predict outcome in acute stroke trials. Stroke 2001;32:909-916
42. Casas JP, Hingorani AD, Bautista LE, et al. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004;61:1652-1661
43. http://locus.umdnj.edu/ninds. Accessed March 11, 2005
44. Foulkes MA, Wolf PA, Price TR, et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988;19:547-554
45. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526
46. Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995;26: 1329-1333
47. Ito D, Murata M, Watanabe K, et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000;31:936-939
48. Kokubo Y, Chowdhury AH, Date C, et al. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000;31:1299-1306
49. Kessler C, Spitzer C, Stauske D, et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997;17:2880-2884
50. Jannes J, Hamilton-Bruce MA, Pilotto L, et al. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 2004;35:1090-1094